Home Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

FPG #8: Alternative Treatments in Psychiatry
FPG #7: Critical Care in Neurology

Free Medical Books

  Inflammatory Bowel Diseases

  Free Subscription


Articles published in Gastroenterol Hepatol

Retrieve available abstracts of 28 articles:
HTML format
Text format



Single Articles


    December 2011
  1. NAVES JE , Domenech E
    [Systemic amyloidosis in inflammatory bowel disease.]
    Gastroenterol Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  2. CABRIADA JL
    [Apheresis in inflammatory bowel disease. a valid option?]
    Gastroenterol Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



    October 2011
  3. IBORRA M , Beltran B, Nos P
    [New knowledge in genetics and inflammatory bowel disease. are there any practical applications?]
    Gastroenterol Hepatol. 2011.
    PubMed     Text format     Related articles   



    August 2011
  4. FERRER I , Maroto N, Monton C, Villagrasa R, et al
    [Miliary tuberculosis in a patient with Crohn's disease].
    Gastroenterol Hepatol. 2011;34:511-3.
    PubMed     Text format     Related articles   



  5. FORTEA-ORMAECHEA JI , Gonzalez-Lama Y, Casis B, Chaparro M, et al
    Adalimumab is effective in long-term real life clinical practice in both luminal and perianal Crohn's disease. The Madrid experience.
    Gastroenterol Hepatol. 2011;34:443-8.
    PubMed     Text format     Related articles    Abstract available



    June 2011
  6. LEGIDO J , Gisbert JP, Mate J
    [Bone metabolism changes in 100 patients with inflammatory bowel disease.]
    Gastroenterol Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



    May 2011
  7. LOPEZ-MARTIN C , Chaparro M, Espinosa L, Bejerano A, et al
    Adverse events of thiopurine immunomodulators in patients with inflammatory bowel disease.
    Gastroenterol Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



    March 2011
  8. GUARNER F
    [The intestinal microbiota and inflammatory bowel disease.]
    Gastroenterol Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



    February 2011
  9. RICART E , Panes J, Benitez-Ribas D
    [Dendritic cells: a new horizon in cell therapy for inflammatory bowel disease?]
    Gastroenterol Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



    January 2011
  10. SANCHEZ CANO D , Ruiz-Villaverde R, Olvera Porcel MC, Callejas Rubio JL, et al
    [Evaluation of bone mineral density, bone turnover markers, the OPG/RANKL system and sTNF-RI in Crohn's disease].
    Gastroenterol Hepatol. 2011;34:3-9.
    PubMed     Text format     Related articles    Abstract available



  11. LOPEZ-MARTIN C , de la Fuente-Fernandez E, Corbaton P, Sanchez MC, et al
    [Nodular regenerative hyperplasia: azathioprine-induced hepatotoxicity in a patient with Crohn's disease].
    Gastroenterol Hepatol. 2011;34:16-9.
    PubMed     Text format     Related articles    Abstract available



  12. ALCALDE VARGAS A , Justiniano JM, Carnerero EL, Salado CT, et al
    [Utility of infliximab therapy in severe enterorrhagia associated with Crohn's disease. Report of three cases].
    Gastroenterol Hepatol. 2011;34:24-8.
    PubMed     Text format     Related articles    Abstract available



    December 2010
  13. LOPEZ-NEGRE JL , Graells J, Orbeal R, Saavedra J, et al
    [Perianal herpes simplex in a patient with Crohn's disease treated with infliximab].
    Gastroenterol Hepatol. 2010;33:758-9.
    PubMed     Text format     Related articles   



    November 2010
  14. ANTON MARTINEZ J , Ortega Gomez A, Arranz Carrero A, Molina Sanchez A, et al
    [Incidence of inflammatory bowel disease in the health area of Navalmoral de la Mata (Caceres, Spain) between 2000 and 2009.]
    Gastroenterol Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



    October 2010
  15. FERRER BRADLEY I , Navarro Perez L, Maroto Arce N, Lopez Serrano A, et al
    [Myiasis caused by Eristalis tenax in Crohn's disease].
    Gastroenterol Hepatol. 2010;33:616-7.
    PubMed     Text format     Related articles   



    June 2010
  16. ROMERO GUTIERREZ M , Alcantara Torres M, Munoz Rosas C, Gomez Moreno AZ, et al
    [Metastatic Crohn's disease].
    Gastroenterol Hepatol. 2010;33:440-4.
    PubMed     Text format     Related articles    Abstract available



  17. PLAZA SANTOS R , Jaquotot Herranz M, Froilan Torres C, Poza Cordon J, et al
    [Leukocytoclastic vasculitis associated with Crohn's disease].
    Gastroenterol Hepatol. 2010;33:433-5.
    PubMed     Text format     Related articles    Abstract available



    May 2010
  18. DIEZ R , Garcia MJ, Vivas S, Arias L, et al
    [Gastrointestinal manifestations in patients with primary immunodeficiencies causing antibody deficiency]
    Gastroenterol Hepatol. 2010;33:347-51.
    PubMed     Text format     Related articles    Abstract available



    April 2010
  19. CEREZO RUIZ A , Lenzano Grande F, Perez De Luque DJ, Dominguez Jimenez JL, et al
    [Leukocytoclastic vasculitis associated with ulcerative colitis.]
    Gastroenterol Hepatol. 2010.
    PubMed     Text format     Related articles   



  20. DOMENECH E , Lopez San Roman A, Garcia-Planella E
    [How long should combined therapy with biological and immunomodulatory agents be maintained in inflammatory bowel disease?]
    Gastroenterol Hepatol. 2010.
    PubMed     Text format     Related articles   



  21. ORDAS I , Salas A, Benitez D, Ricart E, et al
    [Rationale for cell therapy in the treatment of inflammatory bowel disease.]
    Gastroenterol Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  22. SIERRA AUSIN M , Rascarachi G, Diez Rodriguez R, Arias Rodriguez L, et al
    [Mesalazine-induced acute pericarditis]
    Gastroenterol Hepatol. 2010;33:338-9.
    PubMed     Text format     Related articles   



  23. FRONTELA C , Canali R, Virgili F
    [Use of dietary phenols to modulate inflammatory bowel response]
    Gastroenterol Hepatol. 2010;33:307-12.
    PubMed     Text format     Related articles    Abstract available



    March 2010
  24. GONZALO V , Petit A, Castellvi-Bel S, Pellise M, et al
    Telomerase mRNA expression and immunohistochemical detection as a biomarker of malignant transformation in patients with inflammatory bowel disease.
    Gastroenterol Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  25. LEAL-VALDIVIESO C , Naves JE, Manosa M, Zabana Y, et al
    [Portal hypertension in patients with inflammatory bowel disease.]
    Gastroenterol Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



    February 2010
  26. GARRIDO E , Van Domselaar M, Morales S, Lopez-Sanroman A, et al
    [Inflammatory bowel disease and pregnancy.]
    Gastroenterol Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



    January 2010
  27. GONZALEZ-LAMA Y , Vera MI, Calvo M, Abreu L, et al
    [Markers of the course of inflammatory bowel disease treated with immunomodulators or biological agents.]
    Gastroenterol Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



    October 2009
  28. MARIN I , Serra I, Manosa M, Cabre E, et al
    [Psoas abscess as a complication of Crohn's disease: report of three cases and literature review]
    Gastroenterol Hepatol. 2009;32:557-61.
    PubMed     Text format     Related articles    Abstract available



Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: